fbpx

Vaccine as Brain Cancer Therapy

Share Button

The day may soon come when surgery, chemo and radiation appear barbaric as brain cancer therapies- vaccines may become the new, effective standard-of-care 

If you have been diagnosed with brain cancer I have good news and I have bad news. First, the bad news. Conventional (FDA approved) oncology has little to offer you other than expensive chemo and radiation with a good chance of nasty collateral damage.

Image result for image of vaccine

Now the good news. As the studies linked and excerpted below explain, vaccines may become the new, effective standard-of-care for brain cancer. The hitch is that this technology is constantly changing. A post I write today, July 24th, 2017, may be out-of-date by the time you read it.

I am both a cancer survivor and cancer coach. I work with cancer patients to research both conventional and non-conventional (vaccines…) therapies for their type and stage of cancer.

Have you been diagnosed with brain cancer? What type? What stage? Please scroll down the page, post a question or comment and I will reply to you ASAP.

Thanks and hang in there,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Survival in Patients with Glioblastoma Receiving Valganciclovir

“Here we present current retrospective data on 50 patients with glioblastoma who received valganciclovir as an add-on to standard therapy at Karolinska University Hospital as adjuvant treatment (Section S2 in the Supplementary Appendix). The rate of survival of treated patients was remarkably high: at 2 years, 62% were alive, as compared with 18% of contemporary controls with a similar disease stage, surgical-resection grade, and baseline treatment…”

Brain Cancer Vaccine Proves Effective, Study Suggests

“A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme…

Antiviral May Boost Survival in Brain Cancer

“Antiviral therapy against cytomegalovirus (CMV) — typically only thought a threat in immunosuppressed patients — was linked to dramatically improved survival in patients with glioblastoma, based on one center’s experience…The results were even better in the subgroup treated longer, up to 70% and 90% 2-year survival…”

Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.

CONCLUSION: These results suggest that intrathecal treatment with PVS-RIPO may be useful for treatment of neoplastic meningitis in patients with glioblastoma multiforme and provides a rationale for clinical trials in this area..”

YouTube video talking about the above therapy on a live GBM cancer patient-http://www.youtube.com/watch?v=UHmQnGsWiIM

Leave a Comment: